Ethics Finance Organization Pharmaceuticals 
Marshall Goldsmith
FEBRUARY 8, 2018
World leading researcher on the impact of leadership in organizations. Antonio Nieto-Rodriguez – Author of the best-selling book: The Focused Organization, Winner of the 2017 Thinkers50 Award for ‘Ideas into Practice’. Darek Lenart – Senior VP HR, Finance MasterCard. World authority on branding and culture transformation.
Harvard Business Review
JUNE 8, 2015
Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products. Experimentation is vital.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
MARCH 24, 2011
sense, it entails a potentially disastrous failure of the imagination, an inability to appreciate all the exigencies the client confronts in trying to actually get something done, much less changed, within his organization. Among McKinsey's biggest clients in the 1990s were pharmaceuticals and financial-services companies.
Harvard Business Review
JANUARY 10, 2013
initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. Generally speaking, these multi-company issues have arisen from bad acts by individuals in the middle of the organization and do not appear to have been directed from the top of the corporation.
Harvard Business Review
SEPTEMBER 19, 2016
Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. From a historical perspective, the idea that managers in organizations have a single, dominant duty — to achieve or maximize economic returns — is a striking development. How should you make this decision?
Expert insights. Personalized for you.
70 
Let's personalize your content